QUALITY CONTROL IN BLOOD BANK

QUALITY CONTROL IN BLOOD BANK

Content Definition Types Need Inclusions How to do that?

Quality Assurance It is the sum total of the organized arrangements with the objective of ensuring that products will be of the quality required for their intended use. It includes retrospective review and analysis of operational performance data to determine that the overall process is in a state of control and to detect shift or trends that require attention.

Quality Control Testing routinely performed tests/activities on materials and equipments to check their proper function The monitoring system that checks the effectiveness of existing process/steps by testing the quality of final products

Quality System Essentials (QSEs) 1. Organization and leadership 2. Facilities work environment and safety 3. Human resources 4. Customer focus 5. Suppliers and material management 6. Equipment management 7. Process management 8. Documents and records 9. Information management 10. Management of non conforming events 11. Monitoring and assessment 12. Process improvement

Types Internal Quality control External Quality Control

Internal Control The internal quality control can be maintained by going through a complete checklist of items or test daily to make sure that all systems are being monitored and in control. Immediate decisions can be taken to accept or reject results / products.

External Quality Control External quality control is a way to compare the performance of a laboratory with reference to other laboratories External Quality Assurance also know as ‘proficiency testing’ or External Quality control

Quality in Blood Transfusion Services In blood transfusion service, the primary goal of quality is 'transfusion of safe unit of blood.' The quality system deals with all aspects to ensure that the product or 'safe unit of blood' is as safe as possible.

Objectives of Quality in Blood Bank To ensure availability of a sufficient supply of blood, blood components of high quality with maximum efficacy and minimum risk to both donors and patients. To determine problems in the whole transfusion chain and solve it to achieve the goal .

Quality Management System in Blood Bank In a blood transfusion center, it means that a management system should exist to look into provision of a safe unit of blood and if any errors are identified, these should be corrected.

Steps involving Quality Control in Blood Bank Donor selection and Blood collection Serology Laboratory Transfusion transmitted Infection Component preparation Cross-match & Antibody screening Storage , issue and transportation

Need for Quality A failure in the quality of blood collected or screening of donated blood unit can be very serious and may result in fatal consequences. 1. 2. 3. 4. 5. Failure to identify the patient correctly Wrong sample labeling Mix-up of results amongst different patients Failure to detect presence of an abnormality in the patient's sample Issue of unscreened blood due to clerical or technical errors

Quality Control for Reagents The primary objective of a reagent quality control is to ensure that reagent is functioning as expected.

Quality Control for Reagents Reagent requirements All reagents should be clearly labeled with batch number, expiry date and storage temp; Instructions for use should be in-form of SOP’s with training. All reagents and kit should be used according to the manufacturer’s instructions. FIFO shall be maintained

Quality Control for Reagents Use of positive & negative controls should be done with each batch to show that reagents are potent and specific. All reagents must be carefully stored at recommended temp. Reagents to be kept at 4-6oC should never be frozen and are stored according to manufacturer’s instructions only Supply, storage and transportation of kits and reagents should be strictly standardized & manufacturer’s instructions should be followed with ensured continuous power supply and periodic temperature monitoring.

Log of Reagents Reagent records should include: The name of each reagent with Lot number Batch number Expiry date Name of manufacturer Date of receipt and put in use Grade and strength of reactions at time of receipt (Kit verification).

Frequency of Quality Control of Reagent Reagents Frequency of testing along with Controls Anti human serum Each day of use Blood grouping serum Each day of use Antibody screening and reverse grouping cells Each day of use Enzymes Each run Normal saline (LISS and BPS) Each day of use Bovine albumin Each day of use

Quality Control of Reagent Red Blood Cells Parameters Quality Requirement Frequency of Control Appearance No haemolysis or turbidity in supernatant by visual inspections Each day Reactivity and specificity Positive reactions with Each day known sera against red blood cells antigens

Quality Control of ABO Reagent (Anti-A, Anti-B and Anti-AB) Parameters Quality Requirement Frequency of Control Appearance No turbidity, precipitate, particles or gel formation by visual inspection Specificity Positive reaction with red cells having corresponding antigen(s); and no reaction with negative control Each day Avidity Macroscopic agglutination with 50% red cells suspension in homologous serum/normal saline using the slide test; 10 seconds for anti-A, anti-B and anti-AB with A1 and/or B cells at R.T; 20 seconds with A2 and A2B cells. Daily and of each new lot/batch Reactivity No immune haemolysis, rouleaux formation or Each new lot/batch. Prozone Undiluted serum should give reactions in Each new lot/batch. saline tube test using a 3% red cells suspensions at R.T., titre should be 256 for anti-A, anti-B, and anti-AB with A1 and/or B cells, 64 with A2 and A2B cells. Potency Daily and of each new lot/batch

Quality Acceptable of Rh Anti-sera (Anti-D) Parameter Quality requirement Frequency of control Appearance No turbidity, precipitation, particles or gel formation by visual inspection Each day Specificity Positive reaction with R1r cells / Known D Positive cells Each day and each new lot/batch. And no reaction with rr cells. Avidity Visible agglutination with 40% red cells suspension in homologous serum using the slide test. Each day and each new lot/batch Reactivity No immune haemolysis, rouleaux formation or prozone phenomenon. Each new lot/batch Potency Undiluted serum gives Each new lot/batch reactions in designated test for each serum and a titre 3264 for anti-D.

Acceptable Titre and Avidity of ABO Reagents Anti-sera Type of the reagent Type of red cells (2-3% cells suspension) Titre Avidity Time Intensity Anti-A Polyclonal Monoclonal A1 A2 A2B O B A1 A2 A2B O B 1:256 1:128 1:64 1:256 1:128 1:64 - 10-12 sec 15-18 sec 15-18 sec 3.4 sec 5-6 sec 5-6 sec - To To - Anti-B Polyclonal Monoclonal B A1B O A1 B A1B O A1 1:256 1:128 1:256 1:128 - 10-12 sec 12-15 sec 3-4 sec 5-6 sec - - Anti-AB Polyclonal Monoclonal A1 B A2 O A1 B A2 O 1:256 1:256 1:64 1:256 1:256 1:128 - 10-12 sec 10-12 sec 15-18 sec 3-4 sec 3-4 sec 5-6 sec - To -

Acceptable Quality of Anti-globulin (Gel / Beads) Reagent Parameter Appearance Reactivity and Specificity Quality requirement No precipitate, particles or gel formation by visual in inspection. No prozone phenomenon Frequency of control Each day No haemolysis or agglutination of unsensitized red cells Each day Agglutination of red cells sensitised with anti-D serum containing not more than 0.2 mg/ml antibody activity Each day and each new lot/batch. Each lot

Transfusion Transmitted Infection testing Done in Blood Bank HBs Ag HIV 1 & 2 HCV Syphilis Malaria Parasite

Frequency of Transfusion Transmitted disease Reagents Frequency of testing along with controls Hepatitis B Antigen Each run HIV 1 & 2 Antibody Each run Hepatitis C Virus Each run Syphilis serology reagents Each run Malaria Test Each run

Assuring quality of examination procedure The daily QC values shall be documented on Levey Jennings curve and CV % from monthly QC data must be calculated.

Flow chart should be made to manage “Out of control situation” If a reagent produces results outside the limits set by the manufacturer or Blood Bank, the deficiency should be reported to the Quality Manager. Search for recent events that could have caused changes Examine environmental condition Follow manufactures troubleshooting guide Refer to manufacturer of equipment, reagents or QC/Calibrator vendor.

Quality Control in Blood/ Blood Components Frequency of Testing 1% of component shall be tested for Quality Control out of which 75% shall match the acceptable ranges as per National guidelines set by Govt. of India(DGHS).

QC of blood/blood component preparation 1. Whole blood: Frequency of control: 1% of all units with minimum of 4 units per month Storage :- 2ºC to 6 ºC, for CPDA-1 the storage time is 35 days, CPD & CD2D – 22days. Parameter Quantity Requirement Frequency of Control Volume 350/450 ml 10% 1% of all units Anticoagulants 49/63 ml All units PCV (Hct) 30 to 40% 4 units per month HBsAg Negative by ELISA All units Anti-HCV Negative by ELISA All units Anti-HIV ½ Negative by ELISA All units Syphilis Negative by Screening test All units Sterility By culture Periodically (1% of all units)

Calculation for Total Volume of Whole Blood taken in 450 ml of Bag Volume of Whole Blood: 450 ml 10% OR 472 gms. 10% Calculate the volume from the formula given below: Weight of the Bag with Blood (gms) Weight of the empty Bag (with Anticoagulant) Volume (ml) 1.05 * Weight of the empty Bag (with Anticoagulant) of 450 ml 100 gms

2. Red cell concentrates Perform the same assay as for Whole blood Storage : 2o-6º C, for 35 days if prepared from WB collected in CPDA-1 The Quality Control of red cell concentrate (Prepared from 450 ml Blood) Parameter Quantity Requirement Frequency of Control Volume 280 40 ml 1% of all units PCV (Hct) 70% 5% Periodically (1% of all units) The Quality Control of red cell in preservative sol. (ADSOL/SAGM) Parameter Quantity Requirement Frequency of Control Volume 350 20 ml 1% of all units PCV (Hct) 55-65% Periodically (1% of all units)

3. Platelet concentrates Prepared within 6 hours of blood collection Must evaluate at least 1% of platelets monthly for platelet count, pH and plasma volume Platelets should be selected from each centrifuge in use Storage : 20o-24ºC Parameter Quality Requirements Frequency of control Volume 50-70 ml All units Platelets count 5.5 x 1010 4 units per month/ 1% of all units (whichever is more) pH 6.0 4 units per month/ 1% of all units (whichever is more) RBC contamination 0.5 ml 4 units per month/ 1% of all units (whichever is more) WBC contamination 5.5x107 –5x108 4 units per month/ 1% of all units (whichever is more)

4. Quality of Platelet concentrate by Apheresis Parameter Quality requirement Volume 200 ml Platelets count 3.0 – 7.0 x 1011 pH 6.0 (at the end of permissible storage period) Residual leucocytes 5.0 x 106 Red cells Traces to 0.5 ml

5. Fresh Frozen Plasma frozen within 6 hours of blood collection using –80oC deep freezers or blast freezers Stored at –30oC Date of expiry one year Parameter Quality control Frequency of control Volume 200–220 Plasma 4 units per month/ 1% of all units (whichever is more) Stable coagulation factors 200 units of each factor 4 units per month Factor VIII 0.7 units/ml 4 units per month Fibrinogen 200–400 mg 4 units per month

6. Cryoprecipitate Parameter Quality control Frequency of control Volume 10–20 ml 1% of all units Factor VIII 80–120 units 1% of all units Fibrinogen 150–250 mg 1% of all units

Labeling Unique identification number ABO and Rh type Date of collection and expiry TTI screening sticker Volume of component

Storage External ambient temperature Range: 2 to 6 C Continuous monitor temperature chart to record ‘fluctuations’ THERMOGRAPHS: Changed weekly & preserve records Bacterial cultures Audible and visual alarm signal Digital temperature display Refrigerators

Deep freezers Temperature recording : Range: -35 C to -40 C Cooling down time: A full load of plasma packs at 25 C takes a max. of 5 hrs for all the packs to reach below -5 C and 30 hrs to below -20 C

Platelet agitator All PCs to be stored only in agitators: continuous gentle flat bedded – 5 days Interruption compromises the viability Temperature monitoring “Swirling” to be checked before issue Regular Quality Control of RDPs and AP-PCs

External Quality Assurance (EQA) Proficiency Testing Programme is designed to evaluate the overall performance and accuracy engaged in blood banking testing. Determine the performance of Individual Blood banks for specific tests or measurement and to monitor Blood Banks continual performance and improvement. To provide additional confidence to Blood Bank / Laboratory clients. It is a blind testing

External Quality Assurance The internal QC should be complemented by regular external quality assurance e.g. participation in a proficiency testing programme Proficiency programme test, coded “normal” and “problem” blood samples are distributed from national or regional reference laboratory to the participants usually 2x to 4x a year.

Parameters / test covered under EQA 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. HBsAg Anti- HIV 1&2 Anti- HCV Syphilis (VDRL) Malarial Parasite NAT ( HBV/ HCV/ HIV-1, HIV-2, HIV-O & HIV-M) Hemoglobin Blood Group Cross-match Antibody Screening & Identification Factor VIII Fibrinogen Sterility Testing APTT

THANK YOU